Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Roederer

Showing results (361-370 of 405) with videos related to

Pageof 41
Sort By:
Nature|December 20, 2013
Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIVMario Roederer, Brandon F Keele, Stephen D Schmidt, et al.
Science (New York, N.Y.)|September 22, 2017
Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaquesLing Xu, Amarendra Pegu, Ercole Rao, et al.
Nature Immunology|October 21, 2010
A model for harmonizing flow cytometry in clinical trialsHolden T Maecker, J Philip McCoy, , et al.
Nature Medicine|May 23, 2018
HIV vaccine candidate activation of hypoxia and the inflammasome in CD14<sup>+</sup> monocytes is associated with a decreased risk of SIV<sub>mac251</sub> acquisitionMonica Vaccari, Slim Fourati, Shari N Gordon, et al.
Biorxiv : the Preprint Server for Biology|January 13, 2025
Transient glycan-shield reduction induces CD4-binding site broadly neutralizing antibodies in SHIV-infected macaquesDaniel J Morris, Jason Gorman, Tongqing Zhou, et al.
Biorxiv : the Preprint Server for Biology|June 21, 2024
HIV-1 neutralizing antibodies in SHIV-infected macaques recapitulate structurally divergent modes of human V2 apex recognition with a single D geneRyan S Roark, Rumi Habib, Jason Gorman, et al.
Nature Medicine|March 13, 2026
A structure-based mRNA vaccine for Nipah virus in healthy adults: a phase 1 trialAurélie Ploquin, Rosemarie D Mason, LaSonji A Holman, et al.
Cell|July 26, 2016
Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A VirusesM Gordon Joyce, Adam K Wheatley, Paul V Thomas, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2017
Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infectionKirsten E Lyke, Andrew S Ishizuka, Andrea A Berry, et al.
The Journal of Experimental Medicine|August 18, 2025
Structural and genetic basis of HIV-1 envelope V2 apex recognition by rhesus broadly neutralizing antibodiesRyan S Roark, Rumi Habib, Jason Gorman, et al.
Pageof 41

Showing results (361-370 of 405) with videos related to

Sort By:
Pageof 41
Nature|December 20, 2013
Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIVMario Roederer, Brandon F Keele, Stephen D Schmidt, et al.
Science (New York, N.Y.)|September 22, 2017
Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaquesLing Xu, Amarendra Pegu, Ercole Rao, et al.
Nature Immunology|October 21, 2010
A model for harmonizing flow cytometry in clinical trialsHolden T Maecker, J Philip McCoy, , et al.
Nature Medicine|May 23, 2018
HIV vaccine candidate activation of hypoxia and the inflammasome in CD14<sup>+</sup> monocytes is associated with a decreased risk of SIV<sub>mac251</sub> acquisitionMonica Vaccari, Slim Fourati, Shari N Gordon, et al.
Biorxiv : the Preprint Server for Biology|January 13, 2025
Transient glycan-shield reduction induces CD4-binding site broadly neutralizing antibodies in SHIV-infected macaquesDaniel J Morris, Jason Gorman, Tongqing Zhou, et al.
Biorxiv : the Preprint Server for Biology|June 21, 2024
HIV-1 neutralizing antibodies in SHIV-infected macaques recapitulate structurally divergent modes of human V2 apex recognition with a single D geneRyan S Roark, Rumi Habib, Jason Gorman, et al.
Nature Medicine|March 13, 2026
A structure-based mRNA vaccine for Nipah virus in healthy adults: a phase 1 trialAurélie Ploquin, Rosemarie D Mason, LaSonji A Holman, et al.
Cell|July 26, 2016
Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A VirusesM Gordon Joyce, Adam K Wheatley, Paul V Thomas, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2017
Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infectionKirsten E Lyke, Andrew S Ishizuka, Andrea A Berry, et al.
The Journal of Experimental Medicine|August 18, 2025
Structural and genetic basis of HIV-1 envelope V2 apex recognition by rhesus broadly neutralizing antibodiesRyan S Roark, Rumi Habib, Jason Gorman, et al.
Pageof 41